Sales decline 8.95% to Rs 358.85 crore
Net profit of Nectar Lifescience rose 63.19% to Rs 2.97 crore in the quarter ended June 2024 as against Rs 1.82 crore during the previous quarter ended June 2023. Sales declined 8.95% to Rs 358.85 crore in the quarter ended June 2024 as against Rs 394.12 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales358.85394.12 -9 OPM %11.099.02 -PBDT20.3818.39 11 PBT4.923.06 61 NP2.971.82 63Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content